Tactile Systems Technology, Inc. (TCMD)
NASDAQ: TCMD · Real-Time Price · USD
27.61
-0.61 (-2.16%)
At close: Feb 4, 2026, 4:00 PM EST
27.63
+0.02 (0.07%)
After-hours: Feb 4, 2026, 4:10 PM EST
TCMD Employees
Tactile Systems Technology had 1,037 employees as of December 31, 2024. The number of employees increased by 45 or 4.54% compared to the previous year.
Employees
1,037
Change (1Y)
45
Growth (1Y)
4.54%
Revenue / Employee
$300,398
Profits / Employee
$17,520
Market Cap
617.13M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 1,037 | 45 | 4.54% |
| Dec 31, 2023 | 992 | 10 | 1.02% |
| Dec 31, 2022 | 982 | -6 | -0.61% |
| Dec 31, 2021 | 988 | 281 | 39.75% |
| Dec 31, 2020 | 707 | 78 | 12.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Varex Imaging | 2,400 |
| Avanos Medical | 2,227 |
| Bioventus | 950 |
| Standard BioTools | 818 |
| Cytek Biosciences | 692 |
| Pacific Biosciences of California | 575 |
| SI-BONE | 349 |
| CeriBell | 281 |
TCMD News
- 1 day ago - Tactile Medical to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 17, 2026 - GlobeNewsWire
- 2 months ago - Tactile Medical to Present at the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 3 months ago - Tactile Systems Technology Analysts Increase Their Forecasts After Better-Than-Expected Q3 Earnings - Benzinga
- 3 months ago - Tactile Systems Technology, Inc. (TCMD) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Tactile Systems Technology, Inc. Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch® Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema - GlobeNewsWire
- 3 months ago - Tactile Medical to Release Third Quarter of Fiscal Year 2025 Financial Results on November 3, 2025 - GlobeNewsWire
- 6 months ago - Tactile Systems Technology, Inc. (TCMD) Q2 2025 Earnings Call Transcript - Seeking Alpha